Syncope and sinus bradycardia from combined use of thalidomide and β-blocker

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 10, 2008, Pages 1033-1035

  Yamaguchi, Takushi ^a  

^a TEINE KEIJINKAI HOSPITAL   (Japan)

Author keywords

blocker; Multiple myeloma; Sinus bradycardia; Syncope; Thalidomide

Indexed keywords

ATENOLOL; ATROPINE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; THALIDOMIDE;

AGED; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; JAPANESE; LEG EDEMA; MALE; MULTIPLE MYELOMA; PACEMAKER; PRIORITY JOURNAL; SINUS BRADYCARDIA; SYNCOPE;

ADRENERGIC BETA-ANTAGONISTS; AGED; BRADYCARDIA; DRUG THERAPY, COMBINATION; HEART RATE; HUMANS; MALE; SYNCOPE; THALIDOMIDE;

EID: 57649158189     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1624     Document Type: Article

References (9)

1. Clark TE, Edom N, Larson J, Lindsey LJ. Thalomid (thalidomide) capsules. A review of the first 18 months of spontaneous postmarketing event surveillance, including off-label prescribing. Drug Saf 2001; 24: 87-117.
2. Mangrum JM, DiMarco JP. The evaluation and management of bradycardia. N Engl J Med 2000; 342: 703-709.
3. Dimopoulos MA, Eleutherakis-Papaiakovou V. Adverse effects of thalidomide administration in patients with neoplastic disease. Am J Med 2004; 117: 508-515.
4. Fahdi IE, Gaddam V, Saucedo JF, et al. Bradycardia during therapy for multiple myeloma with thalidomide. Am J Cardiol 2004; 93: 1052-1055.
5. Singhal S, Mehta J. Thalidomide in cancer: potential uses and limitations. BioDrugs 2001; 15: 163-172.
6. Rajkumar SV, Gertz MA, Lacy MQ, et al. Thalidomide as initial therapy for early-stage myeloma. Leukemia 2003; 17: 775-779.
7. Kaur A, Yu SS, Lee AJ, Chiao TB. Thalidomide-induced sinus bradycardia. Ann Pharmacother 2003; 37: 1040-1043.
8. Badros AZ, Siegel E, Bodenner D, et al. Hypothyroidism in patients with multiple myeloma following treatment with thalidomide. Am J Med 2002; 112: 412-413.
9. Emch GS, Hermann GE, Rogers RC. Tumor necrosis factor-α inhibits physiologically identified dorsal motor nucleus neurons in vivo. Brain Res 2002; 951: 311-315.